Crossref
A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells
American Journal of Medical Sciences and Medicine · 09.07.2026 · 14 (2) · 25-31
DOI: 10.12691/ajmsm-14-2-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Sciences and Medicine, erschienen am 09.07.2026. Verfasst von Hafkenscheid K. und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
K., H., B., J., A., M., A., G., C., P., P., J., AJ., D., & T., W. (2026). A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells. American Journal of Medical Sciences and Medicine, 14(2), 25-31. https://doi.org/10.12691/ajmsm-14-2-2
Vancouver
K. H, B. J, A. M, A. G, C. P, P. J, et al. A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells. American Journal of Medical Sciences and Medicine. 2026;14(2):25-31. doi:10.12691/ajmsm-14-2-2
BibTeX
@article{K2026,
author = {K., Hafkenscheid and B., Jacuinde and A., Mari and A., Gomez and C., Philip and P., Jay and AJ., Diaz and T., Wang},
title = {A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells},
journal = {American Journal of Medical Sciences and Medicine},
year = {2026},
volume = {14},
number = {2},
pages = {25--31},
doi = {10.12691/ajmsm-14-2-2}
}
EUVIMED